These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1105 related items for PubMed ID: 25180925

  • 1. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
    Ma LY, Pang LP, Wang B, Zhang M, Hu B, Xue DQ, Shao KP, Zhang BL, Liu Y, Zhang E, Liu HM.
    Eur J Med Chem; 2014 Oct 30; 86():368-80. PubMed ID: 25180925
    [Abstract] [Full Text] [Related]

  • 2. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
    Duan YC, Ma YC, Zhang E, Shi XJ, Wang MM, Ye XW, Liu HM.
    Eur J Med Chem; 2013 Apr 30; 62():11-9. PubMed ID: 23353743
    [Abstract] [Full Text] [Related]

  • 3. Design and synthesis of novel 1,2,3-triazole-pyrimidine-urea hybrids as potential anticancer agents.
    Ma LY, Wang B, Pang LP, Zhang M, Wang SQ, Zheng YC, Shao KP, Xue DQ, Liu HM.
    Bioorg Med Chem Lett; 2015 Mar 01; 25(5):1124-8. PubMed ID: 25655718
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and biological evaluation of novel pyrimidine-benzimidazol hybrids as potential anticancer agents.
    Shao KP, Zhang XY, Chen PJ, Xue DQ, He P, Ma LY, Zheng JX, Zhang QR, Liu HM.
    Bioorg Med Chem Lett; 2014 Aug 15; 24(16):3877-81. PubMed ID: 25001482
    [Abstract] [Full Text] [Related]

  • 5. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
    Kandeel MM, Refaat HM, Kassab AE, Shahin IG, Abdelghany TM.
    Eur J Med Chem; 2015 Jan 27; 90():620-32. PubMed ID: 25499930
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis and antiproliferative activity studies of novel 1,2,3-triazole-dithiocarbamate-urea hybrids.
    Duan YC, Zheng YC, Li XC, Wang MM, Ye XW, Guan YY, Liu GZ, Zheng JX, Liu HM.
    Eur J Med Chem; 2013 Jun 27; 64():99-110. PubMed ID: 23644193
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and anticancer activities of novel 1,2,4-triazolo[3,4-a]phthalazine derivatives.
    Xue DQ, Zhang XY, Wang CJ, Ma LY, Zhu N, He P, Shao KP, Chen PJ, Gu YF, Zhang XS, Wang CF, Ji CH, Zhang QR, Liu HM.
    Eur J Med Chem; 2014 Oct 06; 85():235-44. PubMed ID: 25086915
    [Abstract] [Full Text] [Related]

  • 8. A novel [1,2,4] triazolo [1,5-a] pyrimidine-based phenyl-linked steroid dimer: synthesis and its cytotoxic activity.
    Yu B, Shi XJ, Zheng YF, Fang Y, Zhang E, Yu DQ, Liu HM.
    Eur J Med Chem; 2013 Nov 06; 69():323-30. PubMed ID: 24077182
    [Abstract] [Full Text] [Related]

  • 9. Design and synthesis of novel 1,2,3-triazole derivatives of coronopilin as anti-cancer compounds.
    Khazir J, Hyder I, Gayatri JL, Prasad Yandrati L, Nalla N, Chasoo G, Mahajan A, Saxena AK, Alam MS, Qazi GN, Sampath Kumar HM.
    Eur J Med Chem; 2014 Jul 23; 82():255-62. PubMed ID: 24910974
    [Abstract] [Full Text] [Related]

  • 10. Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity.
    Shi JB, Tang WJ, Qi XB, Li R, Liu XH.
    Eur J Med Chem; 2015 Jan 27; 90():889-96. PubMed ID: 25554922
    [Abstract] [Full Text] [Related]

  • 11. Rational design, synthesis and anti-proliferative evaluation of novel 1,4-benzoxazine-[1,2,3]triazole hybrids.
    Bollu R, Palem JD, Bantu R, Guguloth V, Nagarapu L, Polepalli S, Jain N.
    Eur J Med Chem; 2015 Jan 07; 89():138-46. PubMed ID: 25462234
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity.
    Pingaew R, Mandi P, Nantasenamat C, Prachayasittikul S, Ruchirawat S, Prachayasittikul V.
    Eur J Med Chem; 2014 Jun 23; 81():192-203. PubMed ID: 24836071
    [Abstract] [Full Text] [Related]

  • 13. Spirooxindole-derived morpholine-fused-1,2,3-triazoles: Design, synthesis, cytotoxicity and apoptosis inducing studies.
    Senwar KR, Sharma P, Reddy TS, Jeengar MK, Nayak VL, Naidu VG, Kamal A, Shankaraiah N.
    Eur J Med Chem; 2015 Sep 18; 102():413-24. PubMed ID: 26301558
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis and in vitro biological evaluation of novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing a thiosemicarbazide moiety.
    Geng PF, Liu XQ, Zhao TQ, Wang CC, Li ZH, Zhang J, Wei HM, Hu B, Ma LY, Liu HM.
    Eur J Med Chem; 2018 Feb 25; 146():147-156. PubMed ID: 29407946
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
    Kassab AE, Hassan RA.
    Bioorg Chem; 2018 Oct 25; 80():531-544. PubMed ID: 30014921
    [Abstract] [Full Text] [Related]

  • 17. Discovery of novel pyrrolopyrimidine/pyrazolopyrimidine derivatives bearing 1,2,3-triazole moiety as c-Met kinase inhibitors.
    Wang L, Liu X, Duan Y, Li X, Zhao B, Wang C, Xiao Z, Zheng P, Tang Q, Zhu W.
    Chem Biol Drug Des; 2018 Jul 25; 92(1):1301-1314. PubMed ID: 29575727
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and biological evaluation of 1,2,3-triazole linked aminocombretastatin conjugates as mitochondrial mediated apoptosis inducers.
    Kamal A, Shaik B, Nayak VL, Nagaraju B, Kapure JS, Shaheer Malik M, Shaik TB, Prasad B.
    Bioorg Med Chem; 2014 Oct 01; 22(19):5155-67. PubMed ID: 25192811
    [Abstract] [Full Text] [Related]

  • 19. New annelated thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines, with potent anticancer activity, designed through VLAK protocol.
    Lauria A, Abbate I, Patella C, Martorana A, Dattolo G, Almerico AM.
    Eur J Med Chem; 2013 Apr 01; 62():416-24. PubMed ID: 23395722
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis and biological evaluation of [1,2,3]triazolo[4,5-d]pyrimidine derivatives possessing a hydrazone moiety as antiproliferative agents.
    Li ZH, Yang DX, Geng PF, Zhang J, Wei HM, Hu B, Guo Q, Zhang XH, Guo WG, Zhao B, Yu B, Ma LY, Liu HM.
    Eur J Med Chem; 2016 Nov 29; 124():967-980. PubMed ID: 27771599
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 56.